Search alternatives:
significantly observed » significantly bolstered (Expand Search), significantly altered (Expand Search), significantly clustered (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significantly observed » significantly bolstered (Expand Search), significantly altered (Expand Search), significantly clustered (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
1
-
2
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
3
Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations.
Published 2025“…<p><b>(A)</b> A significant reduction in colony-forming ability was observed in U87MG cells treated with 100ΜM SHG-44 compared to 100ΜM cis-platin and the untreated control. …”
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count.
Published 2025“…(B) Long-term-treatment with a low dose of netoglitazone also exhibits a patchy effect in decreasing plaque count. This effect is mainly observed in the olfactory, hindbrain, and visual areas. …”
-
17
Inotodiol decreases clone formation in HCC cells.
Published 2025“…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”
-
18
-
19
-
20
Effects of busulfan treatment on the ultrastructure of the blood-testis barrier (BTB).
Published 2025Subjects: